Risankizumab (RISA)

BIOLOGICAL2 trials

Sponsors

Alimentiv Inc., Caja Costarricense de Seguro Social

Conditions

Crohn's DiseasePsoriasisPsoriasis (PsO)Psoriasis Arthritis

Unknown Phase

VOICE-Early Response to Vedolizumab and IL-23 Antagonists in Participants With Crohn's Disease: A Prospective Observational Study

Active, not recruitingNCT06249555

Alimentiv Inc.Crohn's Disease

Start: 2024-03-20End: 2026-12-01Target: 300Updated: 2026-08-21

Costa Rican Registry of IL-23 Inhibitors in Psoriatic Disease

Not yet recruitingNCT07448402

Caja Costarricense de Seguro SocialPsoriasis, Psoriasis Arthritis, Psoriasis (PsO)

Start: 2026-05-01End: 2031-05-01Target: 50Updated: 2026-03-09